SIGNAL-DRIVEN SALES

Act on Executive-Hire Signals First

Track leadership moves and score urgency so you reach new decision-makers during their evaluation window.

10–25 decision-maker leads daily • First-90-days targeting • Intent scoring

Every plan includes:

✓Signal-Driven Leads Based on YOUR ICP

✓Role-aware buyer intent scoring

✓Direct outreach workflows

INDUSTRY FIRST

4 Dmt Appoints Uneek Mehra As Chief Financial and Business

Sep 12, 2023•about 2 years ago

Position

Chief Financial And Business

Company

4D Molecular Therapeutics Inc

Uneek Mehra

EmeryvilleGeneticsTherapeuticsHealth CareBiotechnology

Description

EMERYVILLE, Calif., Sept. 12, 2023 -- 4D Molecular Therapeutics , a clinical-stage biotherapeutics company harnessing the power of directed evolution for targeted genetic medicines, today announced the appointment of Uneek Mehra as Chief Financial & Business Officer of 4DMT. Mr

Company Information

Company

4D Molecular Therapeutics Inc

Location

Emeryville, California, United States

About

4DMT is a clinical stage biopharma company inventing and developing innovative products to unlock the full potential of genetic medicine to treat large market and rare diseases. Our vector discovery platform Therapeutic Vector Evolution harnesses the power of directed evolution, a Nobel Prize-winning technology, with approximately one billion synthetic AAV capsid-derived sequences to invent customized and evolved vectors with improved therapeutic profiles compared to wild-type vectors. Our product design, development and manufacturing engine empowers us to efficiently create our valuable and diverse product pipeline. This combination of bold innovation and relentless execution gives 4DMT the capability to revolutionize genetic medicines and to strive for potential curative therapies. We have built a deep portfolio of genetic medicine product candidates, with five product candidates in clinical trials for seven patient populations.